Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
11 stopped studies mapped to Malignant Germ Cell Tumor and descendants · 91% state a reason
Over the 11 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT06191575 | 7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen… | — | suspended | Jan 5, 2024 | University of Southern California | Study team is conducting interim analysis. | Efficacy / futility |
| NCT06275854 | YASU Research Registry: For Young Adults With Cancer | — | terminated | Feb 23, 2024 | Young Adult Survivors United | Sponsoring organization no longer desired to recruit/maintain registry | Enrollment / accrual |
| NCT01593241 | Therapy De-escalation in Seminoma Stage IIA/B | Phase 2 | terminated | May 8, 2012 | Swiss Cancer Institute | Board decided to prematurely terminate the follow-up phase of the trial due to funding reasons | Funding |
| NCT04402593 | Music Therapy For The Treatment Of Cisplatin Induced Tinnitus In Patients With rGCC: A… | N/A | withdrawn | May 27, 2020 | Indiana University | Due to staffing changes and no potential subjects at this time. | Other (stated, no rule matched) |
| NCT01055067 | ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors | Phase 2 | terminated | Jan 25, 2010 | Daiichi Sankyo | The study was terminated early for futility according to the stopping rule of the Simon 2-stage… | Efficacy / futility |
| NCT02689219 | Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors | Phase 2 | terminated | Feb 23, 2016 | Nabil Adra | lack of funding/ benefit | Funding |
| NCT01159067 | Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and… | Phase 2 | terminated | Jul 9, 2010 | City of Hope Medical Center | Low enrollment | Enrollment / accrual |
| NCT01808534 | Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors | Phase 2 | terminated | Mar 11, 2013 | Indiana University | Due to Low Accrual | Enrollment / accrual |
| NCT01088763 | Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or… | Phase 1 | terminated | Mar 17, 2010 | National Cancer Institute (NCI) | not stated | Not stated |
| NCT00042952 | Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage… | Phase 2 | terminated | Jan 27, 2003 | National Cancer Institute (NCI) | Administratively complete. | Other (stated, no rule matched) |
| NCT01558778 | Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem… | N/A | withdrawn | Mar 20, 2012 | Roswell Park Cancer Institute | device not available | Other (stated, no rule matched) |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 22 days agoSource updated Jun 5, 2026source: clinicaltrials